Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.
about
Brinp1(-/-) mice exhibit autism-like behaviour, altered memory, hyperactivity and increased parvalbumin-positive cortical interneuron densityFood cravings, appetite, and snack-food consumption in response to a psychomotor stimulant drug: the moderating effect of "food-addiction".Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studiesPatterns of psychotropic medication prescriptions by psychiatrists for private clinic outpatients in kerman province, iran.The impact of synapsin III gene on the neurometabolite level alterations after single-dose methylphenidate in attention-deficit hyperactivity disorder patients.A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective.Exposure to methylphenidate during infancy and adolescence in non-human animals and sensitization to abuse of psychostimulants later in life: a systematic review.Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder.Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice.DAT1 methylation is associated with methylphenidate response on oppositional and hyperactive-impulsive symptoms in children and adolescents with ADHD.Changes in the serum levels of brain-derived neurotrophic factor in adults with attention deficit hyperactivity disorder after treatment with atomoxetine.Exocytosis-related genes and response to methylphenidate treatment in adults with ADHD.Genotyping of single nucleotide polymorphisms related to attention-deficit hyperactivity disorder.
P2860
Q27322895-75F764E2-BB64-4AD2-8011-F84E2A8535DEQ33611691-A0386CE3-0283-41CE-AE5E-13519EEBE7E1Q33629493-2C68B6DD-AE4C-480A-96B0-48B2F01B7559Q33982992-2CB0A5F2-EF2F-420E-8234-17C598DA8129Q36908416-717FC873-963B-42C7-8458-71A4099C160BQ37115696-14C6CC77-22C5-4E5D-A9E4-DBA39D895DFEQ38243174-622E37BD-8F2F-47AE-B32F-7848F4881889Q38656883-166B39EB-F40D-45E2-83BA-6D50F8BA1FF3Q47550540-259D29B2-4453-42DD-B054-A079713ADF23Q47865542-032837AE-AEE7-458C-8114-00C7DD038B30Q47927866-EDD973CE-20AC-4E0C-ACE9-9889DBDF96C8Q48887356-5E9F1F2C-DD3C-4844-B748-504C64CB54C9Q50684186-0412A519-4C59-413C-AB37-7476D18E9F76Q54574135-C41703C9-496F-486D-846E-DF1CBDC54F81
P2860
Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacogenetics of response t ...... r (ADHD): a systematic review.
@en
type
label
Pharmacogenetics of response t ...... r (ADHD): a systematic review.
@en
prefLabel
Pharmacogenetics of response t ...... r (ADHD): a systematic review.
@en
P50
P1476
Pharmacogenetics of response t ...... er (ADHD): a systematic review
@en
P2093
Marcelo M Victor
Verônica Contini
P304
P356
10.1016/J.EURONEURO.2012.05.006
P407
P577
2012-06-17T00:00:00Z